{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:29:02Z","timestamp":1780338542362,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1579-1","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T13:43:58Z","timestamp":1519220638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Linh","family":"Ngo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Gertner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"1579_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaad.2014.02.035","volume":"71","author":"ME Lacouture","year":"2014","unstructured":"Lacouture ME, Wolchok JD, Yosipovitch G, K\u00e4hler KC, Busam KJ, Hauschild A. Ipilimumab in patients with cancer and the management of dermatologic adverse events. J Am Acad Dermatol. 2014;71:161\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"1579_CR2","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1073\/pnas.0830997100","volume":"100","author":"FS Hodi","year":"2003","unstructured":"Hodi FS, Mihm MC, Soiffer RJ, Haluska FG, Butler M, Seiden MV, et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A. 2003;100:4712\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1579_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/CMR.0000000000000017","volume":"23","author":"S Pintova","year":"2013","unstructured":"Pintova S, Sidhu H, Friedlander PA, Holcombe RF. Sweet\u2019s syndrome in a patient with metastatic melanoma after ipilimumab therapy. Melanoma Res. 2013;23:498\u2013501.","journal-title":"Melanoma Res"},{"key":"1579_CR4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/cncr.27969","volume":"119","author":"JS Weber","year":"2013","unstructured":"Weber JS, Dummer R, de Pril V, Lebb\u00e9 C, Hodi FS. MDX010-20 Investigators. Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma. Cancer. 2013;119:1675\u201382.","journal-title":"Cancer"},{"key":"1579_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1200\/JCO.2016.68.2005","volume":"35","author":"J Naidoo","year":"2017","unstructured":"Naidoo J, Wang X, Woo KM, Iyriboz T, Halpenny D, Cunningham J, et al. Pneumonitis in patients treated with anti-programmed death-1\/programmed death ligand 1 therapy. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35:709\u201317.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1579_CR6","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1001\/jamaoncol.2016.2453","volume":"2","author":"M Nishino","year":"2016","unstructured":"Nishino M, Giobbie-Hurder A, Hatabu H, Ramaiya NH, Hodi FS. Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis. JAMA Oncol. 2016;2:1607\u201316.","journal-title":"JAMA Oncol"},{"key":"1579_CR7","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1158\/1078-0432.CCR-16-1320","volume":"22","author":"M Nishino","year":"2016","unstructured":"Nishino M, Ramaiya NH, Awad MM, Sholl LM, Maattala JA, Taibi M, et al. PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course. Clin Cancer Res Off J Am Assoc Cancer Res. 2016;22:6051\u201360.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"1579_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711\u201323.","journal-title":"N Engl J Med"},{"key":"1579_CR9","doi-asserted-by":"crossref","unstructured":"Kong YM, Flynn JC. Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1. Front Immunol [Internet]. 2014;5. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4032988\/ . Accessed 18 Apr 2017.","DOI":"10.3389\/fimmu.2014.00206"},{"key":"1579_CR10","first-page":"991","volume":"22","author":"S Wilgenhof","year":"2011","unstructured":"Wilgenhof S, Neyns B. Anti-CTLA-4 antibody-induced Guillain-Barr\u00e9 syndrome in a melanoma patient. Ann Oncol Off J Eur Soc. Med Oncol. 2011;22:991\u20133.","journal-title":"Med Oncol"},{"key":"1579_CR11","first-page":"478","volume":"27","author":"MR Robinson","year":"2004","unstructured":"Robinson MR, Chan C-C, Yang JC, Rubin BI, Gracia GJ, Sen HN, et al. Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis. J Immunother Hagerstown Md. 1997. 2004;27:478\u20139.","journal-title":"J Immunother Hagerstown Md. 1997"},{"key":"1579_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/annrheumdis-2016-209595","volume":"76","author":"LC Cappelli","year":"2017","unstructured":"Cappelli LC, Gutierrez AK, Baer AN, Albayda J, Manno RL, Haque U, et al. Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab. Ann Rheum Dis. 2017;76:43\u201350.","journal-title":"Ann Rheum Dis"},{"key":"1579_CR13","unstructured":"RS3PE revisited: a systematic review and meta-analysis of 331 cases [Internet]. http:\/\/www.clinexprheumatol.org\/abstract.asp?a=9559 . Accessed 6 Apr 2017."},{"key":"1579_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/0022-3859.147038","volume":"61","author":"A Varshney","year":"2015","unstructured":"Varshney A, Singh N. Syndrome of remitting seronegative symmetrical synovitis with pitting edema: A case series. J Postgrad Med. 2015;61:38\u201341.","journal-title":"J Postgrad Med"},{"key":"1579_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/art.21067","volume":"53","author":"A Klauser","year":"2005","unstructured":"Klauser A, Frauscher F, Halpern EJ, Mur E, Springer P, Judmaier W, et al. Remitting seronegative symmetrical synovitis with pitting edema of the hands: ultrasound, color doppler ultrasound, and magnetic resonance imaging findings. Arthritis Rheum. 2005;53:226\u201333.","journal-title":"Arthritis Rheum"},{"key":"1579_CR16","doi-asserted-by":"crossref","unstructured":"Gauci M-L, Baroudjian B, Laly P, Madelaine I, Meda LD, Vercellino L, et al. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by Nivolumab. Semin Arthritis Rheum [Internet]. http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0049017216303614 . Accessed 8 Apr 2017.","DOI":"10.1016\/j.semarthrit.2017.03.003"},{"key":"1579_CR17","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1001\/jama.1985.03360190069027","volume":"254","author":"DJ McCarty","year":"1985","unstructured":"McCarty DJ, O\u2019Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA. 1985;254:2763\u20137.","journal-title":"JAMA"},{"key":"1579_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3899\/jrheum.110558","volume":"39","author":"M Kimura","year":"2012","unstructured":"Kimura M, Tokuda Y, Oshiawa H, Yoshida K, Utsunomiya M, Kobayashi T, et al. Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting edema compared to patients with pure polymyalgia rheumatica. J Rheumatol. 2012;39:148\u201353.","journal-title":"J Rheumatol"},{"key":"1579_CR19","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/S0025-6196(11)61095-1","volume":"82","author":"ID Bucaloiu","year":"2007","unstructured":"Bucaloiu ID, Olenginski TP, Harrington TM. Remitting seronegative symmetrical synovitis with pitting edema syndrome in a rural tertiary care practice: a retrospective analysis. Mayo Clin Proc. 2007;82:1510\u20135.","journal-title":"Mayo Clin Proc"},{"key":"1579_CR20","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00296-011-1849-3","volume":"32","author":"T Okumura","year":"2012","unstructured":"Okumura T, Tanno S, Ohhira M, Nozu T. The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan. Rheumatol Int. 2012;32:1695\u20139.","journal-title":"Rheumatol Int"},{"key":"1579_CR21","first-page":"S53","volume":"18","author":"I Olivieri","year":"2000","unstructured":"Olivieri I, Salvarani C, Cantini F. RS3PE syndrome: an overview. Clin Exp Rheumatol. 2000;18:S53\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"1579_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/ard.58.4.230","volume":"58","author":"F Cantini","year":"1999","unstructured":"Cantini F, Salvarani C, Olivieri I, Barozzi L, Macchioni L, Niccoli L, et al. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study. Ann Rheum Dis. 1999;58:230\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1579_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11926-015-0525-0","volume":"17","author":"H Li","year":"2015","unstructured":"Li H, Altman RD, Yao Q. RS3PE: clinical and research development. Curr Rheumatol Rep. 2015;17:49.","journal-title":"Curr Rheumatol Rep"},{"key":"1579_CR24","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/0961203314533601","volume":"23","author":"MO Hegazi","year":"2014","unstructured":"Hegazi MO, Saleh F, Al Rashidi A, Yaktien MM. Synovitis with pitting edema as the presenting manifestation of systemic lupus erythematosus. Lupus. 2014;23:1069\u201372.","journal-title":"Lupus"},{"key":"1579_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3346\/jkms.2003.18.6.921","volume":"18","author":"P Fietta","year":"2003","unstructured":"Fietta P, Manganelli P. Sj\u00f6gren\u2019s syndrome presenting as remitting seronegative symmetric synovitis with pitting edema (RS3PE): comment of the article by Choi et al. J Korean Med Sci. 2003;18:921.","journal-title":"J Korean Med Sci"},{"key":"1579_CR26","first-page":"53","volume":"62","author":"T Billey","year":"1995","unstructured":"Billey T, Navaux F, Lassoued S. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) as the first manifestation of periarteritis nodosa. Report of a case. Rev Rhum Engl Ed. 1995;62:53\u20134.","journal-title":"Rev Rhum Engl Ed"},{"key":"1579_CR27","first-page":"375","volume":"22","author":"AC Koeger","year":"1995","unstructured":"Koeger AC, Karmochkine M, Cha\u00efbi P. RS3PE syndrome associated with advanced ankylosing spondylitis. J Rheumatol. 1995;22:375\u20136.","journal-title":"J Rheumatol"},{"key":"1579_CR28","first-page":"1696","volume":"28","author":"A Torres","year":"2001","unstructured":"Torres A, Cuende E, De Pablos M, Lezaun MJ, Michaus L, Vesga JC. Remitting seronegative symmetrical synovitis with pitting edema associated with subcutaneous Streptobacillus moniliformis abscess. J Rheumatol. 2001;28:1696\u20138.","journal-title":"J Rheumatol"},{"key":"1579_CR29","first-page":"389","volume":"32","author":"CE Perandones","year":"2005","unstructured":"Perandones CE, Colmegna I, Arana RM. Parvovirus B19: another agent associated with remitting seronegative symmetrical synovitis with pitting edema. J Rheumatol. 2005;32:389\u201390.","journal-title":"J Rheumatol"},{"key":"1579_CR30","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1111\/ijd.12854","volume":"54","author":"F Drago","year":"2015","unstructured":"Drago F, Ciccarese G, Agnoletti AF, Cogorno L, Muda A, Cozzani E, et al. Remitting seronegative symmetrical synovitis with pitting edema associated with parvovirus B19 infection: two new cases and review of the comorbidities. Int J Dermatol. 2015;54:e389\u201393.","journal-title":"Int J Dermatol"},{"key":"1579_CR31","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.2337\/dc11-1995","volume":"35","author":"K Yamauchi","year":"2012","unstructured":"Yamauchi K, Sato Y, Yamashita K, Funase Y, Kaneko T, Hashimoto T, et al. RS3PE in association with dipeptidyl peptidase-4 inhibitor: report of two cases. Diabetes Care. 2012;35:e7.","journal-title":"Diabetes Care"},{"key":"1579_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s11845-009-0348-y","volume":"180","author":"D Smyth","year":"2011","unstructured":"Smyth D, Rehman R, Remund K, Egan J. Remitting seronegative symmetrical synovitis with pitting oedema associated with rifampicin. Ir J Med Sci. 2011;180:585\u20136.","journal-title":"Ir J Med Sci"},{"key":"1579_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.12659\/AJCR.890318","volume":"15","author":"NR Mainali","year":"2014","unstructured":"Mainali NR, Schmidt TR, Alweis R, George DL. Novel development of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome due to insulin therapy. Am J Case Rep. 2014;15:119\u201322.","journal-title":"Am J Case Rep"},{"key":"1579_CR34","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1136\/ard.2004.032995","volume":"64","author":"K Arima","year":"2005","unstructured":"Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M, et al. RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis. 2005;64:1653\u20135.","journal-title":"Ann Rheum Dis"},{"key":"1579_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s10067-003-0840-0","volume":"23","author":"M Matsuda","year":"2004","unstructured":"Matsuda M, Sakurai K, Fushimi T, Yamamoto K, Rokuhara S, Hosaka N, et al. Sarcoidosis with high serum levels of vascular endothelial growth factor (VEGF), showing RS3PE-like symptoms in extremities. Clin Rheumatol. 2004;23:246\u20138.","journal-title":"Clin Rheumatol"},{"key":"1579_CR36","first-page":"H586","volume":"265","author":"DD Ku","year":"1993","unstructured":"Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Phys. 1993;265:H586\u201392.","journal-title":"Am J Phys"},{"key":"1579_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/j.seminoncol.2014.02.007","volume":"41","author":"K Mittal","year":"2014","unstructured":"Mittal K, Ebos J, Rini B. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond. Semin Oncol. 2014;41:235\u201351.","journal-title":"Semin Oncol"},{"key":"1579_CR38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3109\/s10165-011-0556-y","volume":"22","author":"T Origuchi","year":"2012","unstructured":"Origuchi T, Arima K, Kawashiri S-Y, Tamai M, Yamasaki S, Nakamura H, et al. High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome. Mod Rheumatol. 2012;22:584\u20138.","journal-title":"Mod Rheumatol"},{"key":"1579_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0049-0172(94)90087-6","volume":"23","author":"D van Schaardenburg","year":"1994","unstructured":"van Schaardenburg D, Breedveld FC. Elderly-onset rheumatoid arthritis. Semin Arthritis Rheum. 1994;23:367\u201378.","journal-title":"Semin Arthritis Rheum"},{"key":"1579_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/PL00011218","volume":"21","author":"S Paira","year":"2002","unstructured":"Paira S, Graf C, Roverano S, Rossini J. Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases. Clin Rheumatol. 2002;21:146\u20139.","journal-title":"Clin Rheumatol"},{"key":"1579_CR41","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/ard.58.11.722","volume":"58","author":"M Gum\u00e1","year":"1999","unstructured":"Gum\u00e1 M, Casado E, Tena X, Oliv\u00e9 A. RS3PE: six years later. Ann Rheum Dis. 1999;58:722\u20133.","journal-title":"Ann Rheum Dis"},{"key":"1579_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00296-003-0330-3","volume":"24","author":"R Queiro","year":"2004","unstructured":"Queiro R. RS3PE syndrome: a clinical and immunogenetical study. Rheumatol Int. 2004;24:103\u20135.","journal-title":"Rheumatol Int"},{"key":"1579_CR43","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong S-J, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19:3635\u201348.","journal-title":"J Clin Oncol"},{"key":"1579_CR44","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong S, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199\u2013206.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T08:56:52Z","timestamp":1570784212000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1579-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1579-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"18 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"48"}}